While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Move strengthens footprint in Western India and expands multi-specialty care network
The company allocated €56 million to research and development for next-generation line solutions
Revvity is positioning its technologies as a connected engine for discovery
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics
Move amid evidence of widespread reporting gaps
Paves the way for next-gen ultra-precise gas sensing
Subscribe To Our Newsletter & Stay Updated
